Caricamento...

Personalized radioiodine therapy for thyroid cancer patients with known disease

Radioactive iodine (RAI) (131)I is a targeted therapy for patients with RAI-avid follicular cell-derived thyroid cancer. However, the responsiveness to (131)I therapy varies among thyroid cancer patients mainly owing to differential RAI uptake and RAI radiosensitivity among patients’ lesions. A pers...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Fac Rev
Autori principali: Jhiang, Sissy M, Cheng, Peng, Nabhan, Fadi A, Sipos, Jennifer A, Menq, Chia-Hsiang
Natura: Artigo
Lingua:Inglês
Pubblicazione: Faculty Opinions Ltd 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8103907/
https://ncbi.nlm.nih.gov/pubmed/33977289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12703/r/10-36
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !